A detailed history of Xtx Topco LTD transactions in Arvinas, Inc. stock. As of the latest transaction made, Xtx Topco LTD holds 18,401 shares of ARVN stock, worth $342,442. This represents 0.03% of its overall portfolio holdings.

Number of Shares
18,401
Holding current value
$342,442
% of portfolio
0.03%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$23.66 - $32.73 $435,367 - $602,264
18,401 New
18,401 $453,000
Q2 2023

Aug 14, 2023

SELL
$21.73 - $31.43 $149,089 - $215,641
-6,861 Reduced 34.44%
13,062 $324,000
Q1 2023

May 12, 2023

BUY
$26.15 - $37.26 $520,986 - $742,330
19,923 New
19,923 $544,000

Others Institutions Holding ARVN

About ARVINAS, INC.


  • Ticker ARVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,205,300
  • Market Cap $990M
  • Description
  • Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...
More about ARVN
Track This Portfolio

Track Xtx Topco LTD Portfolio

Follow Xtx Topco LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.